Which TNF inhibitor has an intravenous dosing option of 2 mg/kg?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Dermatology Week 1 Exam with comprehensive study materials. Practice with detailed questions, flashcards, and expert explanations. Boost your knowledge and confidence for the exam!

Multiple Choice

Which TNF inhibitor has an intravenous dosing option of 2 mg/kg?

Explanation:
TNF inhibitors differ in how you give them and how the dose is determined. Among these agents, only one is given intravenously with a weight-based dose of 2 mg/kg. This IV regimen is administered as an infusion at the start and again at week 4, then every 8 weeks thereafter. The other drugs are used mainly as subcutaneous injections with fixed dosing schedules: one is given as 40 mg SC every other week, another as 50 mg SC weekly, and the last with loading doses of 400 mg at weeks 0, 2, and 4 followed by 200 mg every 2 weeks. So the 2 mg/kg IV option specifically points to golimumab.

TNF inhibitors differ in how you give them and how the dose is determined. Among these agents, only one is given intravenously with a weight-based dose of 2 mg/kg. This IV regimen is administered as an infusion at the start and again at week 4, then every 8 weeks thereafter. The other drugs are used mainly as subcutaneous injections with fixed dosing schedules: one is given as 40 mg SC every other week, another as 50 mg SC weekly, and the last with loading doses of 400 mg at weeks 0, 2, and 4 followed by 200 mg every 2 weeks. So the 2 mg/kg IV option specifically points to golimumab.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy